Global (United States, European Union and China) Transdermal Testosterone Market Research Report 2019-2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Transdermal Testosterone Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Gel
- 1.3.3 Patch
- 1.3.4 Solution
- 1.4 Market Segment by Application
- 1.4.1 Global Transdermal Testosterone Market Share by Application (2019-2025)
- 1.4.2 Primary hypogonadism
- 1.4.3 Hypogonadotropic hypogonadism
- 1.4.4 Late-onset hypogonadism
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Transdermal Testosterone Market Size
- 2.1.1 Global Transdermal Testosterone Revenue 2014-2025
- 2.1.2 Global Transdermal Testosterone Sales 2014-2025
- 2.2 Transdermal Testosterone Growth Rate by Regions
- 2.2.1 Global Transdermal Testosterone Sales by Regions 2014-2019
- 2.2.2 Global Transdermal Testosterone Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Transdermal Testosterone Sales by Manufacturers
- 3.1.1 Transdermal Testosterone Sales by Manufacturers 2014-2019
- 3.1.2 Transdermal Testosterone Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Transdermal Testosterone Revenue by Manufacturers (2014-2019)
- 3.2.2 Transdermal Testosterone Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Transdermal Testosterone Market Concentration Ratio (CR5 and HHI)
- 3.3 Transdermal Testosterone Price by Manufacturers
- 3.4 Key Manufacturers Transdermal Testosterone Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Transdermal Testosterone Market
- 3.6 Key Manufacturers Transdermal Testosterone Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Gel Sales and Revenue (2014-2019)
- 4.1.2 Patch Sales and Revenue (2014-2019)
- 4.1.3 Solution Sales and Revenue (2014-2019)
- 4.2 Global Transdermal Testosterone Sales Market Share by Type
- 4.3 Global Transdermal Testosterone Revenue Market Share by Type
- 4.4 Transdermal Testosterone Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Transdermal Testosterone Sales by Application
6 United States
- 6.1 United States Transdermal Testosterone Breakdown Data by Company
- 6.2 United States Transdermal Testosterone Breakdown Data by Type
- 6.3 United States Transdermal Testosterone Breakdown Data by Application
7 European Union
- 7.1 European Union Transdermal Testosterone Breakdown Data by Company
- 7.2 European Union Transdermal Testosterone Breakdown Data by Type
- 7.3 European Union Transdermal Testosterone Breakdown Data by Application
8 China
- 8.1 China Transdermal Testosterone Breakdown Data by Company
- 8.2 China Transdermal Testosterone Breakdown Data by Type
- 8.3 China Transdermal Testosterone Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Transdermal Testosterone Breakdown Data by Company
- 9.2 Rest of World Transdermal Testosterone Breakdown Data by Type
- 9.3 Rest of World Transdermal Testosterone Breakdown Data by Application
- 9.4 Rest of World Transdermal Testosterone Breakdown Data by Countries
- 9.4.1 Rest of World Transdermal Testosterone Sales by Countries
- 9.4.2 Rest of World Transdermal Testosterone Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 AbbVie
- 10.1.1 AbbVie Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Transdermal Testosterone
- 10.1.4 Transdermal Testosterone Product Introduction
- 10.1.5 AbbVie Recent Development
- 10.2 Teva
- 10.2.1 Teva Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Transdermal Testosterone
- 10.2.4 Transdermal Testosterone Product Introduction
- 10.2.5 Teva Recent Development
- 10.3 Perrigo
- 10.3.1 Perrigo Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Transdermal Testosterone
- 10.3.4 Transdermal Testosterone Product Introduction
- 10.3.5 Perrigo Recent Development
- 10.4 Endo Pharmaceuticals
- 10.4.1 Endo Pharmaceuticals Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Transdermal Testosterone
- 10.4.4 Transdermal Testosterone Product Introduction
- 10.4.5 Endo Pharmaceuticals Recent Development
- 10.5 Acerus Pharmaceuticals
- 10.5.1 Acerus Pharmaceuticals Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Transdermal Testosterone
- 10.5.4 Transdermal Testosterone Product Introduction
- 10.5.5 Acerus Pharmaceuticals Recent Development
- 10.6 Lupin
- 10.6.1 Lupin Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Transdermal Testosterone
- 10.6.4 Transdermal Testosterone Product Introduction
- 10.6.5 Lupin Recent Development
- 10.7 Dr. Reddy's Laboratories
- 10.7.1 Dr. Reddy's Laboratories Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Transdermal Testosterone
- 10.7.4 Transdermal Testosterone Product Introduction
- 10.7.5 Dr. Reddy's Laboratories Recent Development
- 10.8 Upsher-Smith Laboratories
- 10.8.1 Upsher-Smith Laboratories Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Transdermal Testosterone
- 10.8.4 Transdermal Testosterone Product Introduction
- 10.8.5 Upsher-Smith Laboratories Recent Development
- 10.9 Allergan
- 10.9.1 Allergan Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Transdermal Testosterone
- 10.9.4 Transdermal Testosterone Product Introduction
- 10.9.5 Allergan Recent Development
- 10.10 Cipla Inc.
- 10.10.1 Cipla Inc. Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Transdermal Testosterone
- 10.10.4 Transdermal Testosterone Product Introduction
- 10.10.5 Cipla Inc. Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Transdermal Testosterone Sales Channels
- 11.2.2 Transdermal Testosterone Distributors
- 11.3 Transdermal Testosterone Customers
12 Market Forecast
- 12.1 Global Transdermal Testosterone Sales and Revenue Forecast 2019-2025
- 12.2 Global Transdermal Testosterone Sales Forecast by Type
- 12.3 Global Transdermal Testosterone Sales Forecast by Application
- 12.4 Transdermal Testosterone Forecast by Regions
- 12.4.1 Global Transdermal Testosterone Sales Forecast by Regions 2019-2025
- 12.4.2 Global Transdermal Testosterone Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Transdermal Testosterone contains testosterone. It is used for hormone replacement in men who are not able to produce enough testosterone (e.g., hypogonadism). This medication is absorbed through the skin, enters your bloodstream, and helps your body reach normal testosterone levels.
In 2019, the market size of Transdermal Testosterone is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Transdermal Testosterone.
This report studies the global market size of Transdermal Testosterone, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Transdermal Testosterone sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
AbbVie
Teva
Perrigo
Endo Pharmaceuticals
Acerus Pharmaceuticals
Lupin
Dr. Reddy's Laboratories
Upsher-Smith Laboratories
Allergan
Cipla Inc.
Market Segment by Product Type
Gel
Patch
Solution
Market Segment by Application
Primary hypogonadism
Hypogonadotropic hypogonadism
Late-onset hypogonadism
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Transdermal Testosterone status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Transdermal Testosterone manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Transdermal Testosterone are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025